CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.29% | 6.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.29% | 6.56% | |||
| Cost of Revenue | -0.35% | 6.30% | |||
| Gross Profit | -2.02% | 6.77% | |||
| SG&A Expenses | 0.85% | -4.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.14% | 1.00% | |||
| Operating Income | -11.68% | 77.51% | |||
| Income Before Tax | -85.72% | 289.98% | |||
| Income Tax Expenses | -83.36% | 419.44% | |||
| Earnings from Continuing Operations | -86.65% | 254.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.65% | 254.89% | |||
| EBIT | -11.68% | 77.51% | |||
| EBITDA | -8.01% | 44.27% | |||
| EPS Basic | -86.65% | 255.11% | |||
| Normalized Basic EPS | -12.68% | 120.62% | |||
| EPS Diluted | -86.96% | 263.16% | |||
| Normalized Diluted EPS | -12.65% | 121.10% | |||
| Average Basic Shares Outstanding | 0.02% | -0.08% | |||
| Average Diluted Shares Outstanding | -0.01% | -0.31% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 6.50% | -0.72% | |||